Nasym

Authorised

This medicine is authorised for use in the European Union

bovine respiratory syncytial virus vaccine (live)

Medicine Veterinary Authorised

Application under evaluation
CVMP opinion
European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Nasym : EPAR - Medicine overview

Reference Number: EMA/287041/2019

English (EN) (81.94 KB - PDF)

First published: 31/07/2019 Last updated: 09/10/2025

Other languages (25)

Product information

Nasym : EPAR - Product information

English (EN) (81.49 KB - PDF)

First published: 31/07/2019 Last updated: 09/10/2025

Other languages (25)

Nasym : EPAR - All authorised presentations

English (EN) (81.94 KB - PDF)

First published: 31/07/2019 Last updated: 09/10/2025

Other languages (25)

Product details

Name of medicine: Nasym
Active substance: live attenuated bovine respiratory syncytial virus (BRSV), strain Lym-56
International non-proprietary name (INN) or common name: bovine respiratory syncytial virus vaccine (live)

Pharmacotherapeutic group

Immunologicals for Bovidae
Cattle
Live viral vaccines
bovine respiratory syncytial virus (BRSV)

Authorisation details

EMA product number: EMEA/V/C/004897

Assessment history

Nasym : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (81.94 KB - PDF)

First published: 05/03/2020 Last updated: 09/10/2025

Nasym : EPAR - Public Assessment report

Adopted Reference Number: EMA/290800/2019

English (EN) (81.49 KB - PDF)

First published: 31/07/2019 Last updated: 09/10/2025

CVMP summary of positive opinion for Nasym

Adopted Reference Number: EMA/CVMP/252872/2019

English (EN) (69.55 KB - PDF)

First published: 24/05/2019

News on Nasym

Topics

This page was last updated on 09/10/2025